Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses

Molecular Immunology

Volumn 52, Issue 3-4, 2012, Pages 264-272

  Hiemstra, Ida H ^a   Bouma, Gerd ^a   Geerts, Dirk ^b   Kraal, Georg ^a   Haan, Joke M M den ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Crohn's disease; Epithelium; Intestinal barrier; Nod2; Toll like receptor

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHEMOKINE; CLAUDIN 3; CLAUDIN 4; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MURAMYL DIPEPTIDE; SHORT HAIRPIN RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6;

ANIMAL CELL; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPOSURE; GENE SILENCING; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ANIMALS; CELLS, CULTURED; CHEMOKINES; CROHN DISEASE; CYTOKINES; EPITHELIAL CELLS; INTESTINAL MUCOSA; INTESTINES; MICE; NOD2 SIGNALING ADAPTOR PROTEIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIGHT JUNCTIONS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

BACTERIA (MICROORGANISMS); MURINAE;

EID: 84862733209     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.06.007     Document Type: Article

References (53)

1. Allen I.C., TeKippe E.M., Woodford R.M., Uronis J.M., Holl E.K., Rogers A.B., Herfarth H.H., Jobin C., Ting J.P. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. Journal of Experimental Medicine 2010, 207:1045-1056.
2. Baumgart D.C., Sandborn W.J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007, 369:1641-1657.
3. Cario E., Brown D., McKee M., Lynch-Devaney K., Gerken G., Podolsky D.K. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. American Journal of Pathology 2002, 160:165-173.
4. Cario E., Gerken G., Podolsky D.K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007, 132:1359-1374.
5. Cone R.A. Barrier properties of mucus. Advanced Drug Delivery Reviews 2009, 61:75-85.
6. Corbett T.H., Griswold D.P., Roberts B.J., Peckham J.C., Schabel F.M. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Research 1975, 35:2434-2439.
7. Dahiya Y., Pandey R.K., Sodhi A. Nod2 downregulates TLR2/1 mediated IL1beta gene expression in mouse peritoneal macrophages. PLoS ONE 2011, 6:e27828.
8. Ey B., Eyking A., Gerken G., Podolsky D.K., Cario E. TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury. Journal of Biological Chemistry 2009, 284:22332-22343.
9. Franks L.M., Hemmings V.J. A cell line from an induced carcinoma of mouse rectum. Journal of Pathology 1978, 124:35-38.
10. Fritz J.H., Girardin S.E., Fitting C., Werts C., Mengin-Lecreulx D., Caroff M., Cavaillon J.M., Philpott D.J., dib-Conquy M. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and. European Journal of Immunology 2005, 35:2459-2470.
11. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. Journal of Immunology 2001, 167:1882-1885.
12. Giaever I., Keese C.R. Micromotion of mammalian cells measured electrically. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:7896-7900.
13. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. Journal of Biological Chemistry 2003, 278:8869-8872.
14. Gutierrez O., Pipaon C., Inohara N., Fontalba A., Ogura Y., Prosper F., Nunez G., Fernandez-Luna J.L. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. Journal of Biological Chemistry 2002, 277:41701-41705.
15. Hedl M., Li J., Cho J.H., Abraham C. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:19440-19445.
16. Hewitt K.J., Agarwal R., Morin P.J. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 2006, 6:186.
17. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
18. Inohara N., Ogura Y., Chen F.F., Muto A., Nunez G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. Journal of Biological Chemistry 2001, 276:2551-2554.
19. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., Foster S.J., Moran A.P., Fernandez-Luna J.L., Nunez G. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. Journal of Biological Chemistry 2003, 278:5509-5512.
20. Johansson M.E., Larsson J.M., Hansson G.C. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(Suppl. 1):4659-4665.
21. Johansson M.E., Phillipson M., Petersson J., Velcich A., Holm L., Hansson G.C. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:15064-15069.
22. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunology 2010, 11:373-384.
23. Kosovac K., Brenmoehl J., Holler E., Falk W., Schoelmerich J., Hausmann M., Rogler G. Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients. Inflammatory Bowel Diseases 2010, 16:1311-1321.
24. Lala S., Ogura Y., Osborne C., Hor S.Y., Bromfield A., Davies S., Ogunbiyi O., Nunez G., Keshav S. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 2003, 125:47-57.
25. Lecat A., Piette J., Legrand-Poels S. The protein Nod2: an innate receptor more complex than previously assumed. Biochemical Pharmacology 2010, 80:2021-2031.
26. Lee J., Tattoli I., Wojtal K.A., Vavricka S.R., Philpott D.J., Girardin S.E. pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. Journal of Biological Chemistry 2009, 284:23818-23829.
27. Lee J.C., Parkes M. Genome-wide association studies and Crohn's disease. Briefings in Functional Genomics 2011, 10:71-76.
28. Lipinski S., Till A., Sina C., Arlt A., Grasberger H., Schreiber S., Rosenstiel P. DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. Journal of Cell Science 2009, 122:3522-3530.
29. Lukacs N.W. Role of chemokines in the pathogenesis of asthma. Nature Reviews Immunology 2001, 1:108-116.
30. Marina-Garcia N., Franchi L., Kim Y.G., Hu Y., Smith D.E., Boons G.J., Nunez G. Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation. Journal of Immunology 2009, 182:4321-4327.
31. Martinon F., Agostini L., Meylan E., Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Current Biology 2004, 14:1929-1934.
32. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272:263-267.
33. Natividad J.M., Petit V., Huang X., de P.G., Jury J., Sanz Y., Philpott D., Garcia Rodenas C.L., McCoy K.D., Verdu E.F. Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1(-/-); Nod2(-/-) Mice. Inflammatory Bowel Diseases 2011.
34. Netea M.G., Ferwerda G., de Jong D.J., Jansen T., Jacobs L., Kramer M., Naber T.H., Drenth J.P., Girardin S.E., Kullberg B.J., Adema G.J., Van der Meer J.W. Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. Journal of Immunology 2005, 174:6518-6523.
35. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
36. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. Journal of Biological Chemistry 2001, 276:4812-4818.
37. Ogura Y., Lala S., Xin W., Smith E., Dowds T.A., Chen F.F., Zimmermann E., Tretiakova M., Cho J.H., Hart J., Greenson J.K., Keshav S., Nunez G. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003, 52:1591-1597.
38. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
39. Root D.E., Hacohen N., Hahn W.C., Lander E.S., Sabatini D.M. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nature Methods 2006, 3:715-719.
40. Sabbah A., Chang T.H., Harnack R., Frohlich V., Tominaga K., Dube P.H., Xiang Y., Bose S. Activation of innate immune antiviral responses by Nod2. Nature Immunology 2009, 10:1073-1080.
41. Saleh M., Elson C.O. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity 2011, 34:293-302.
42. Salim S.Y., Soderholm J.D. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflammatory Bowel Diseases 2011, 17:362-381.
43. Strober W., Murray P.J., Kitani A., Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nature Reviews Immunology 2006, 6:9-20.
44. Tada H., Aiba S., Shibata K., Ohteki T., Takada H. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infection and Immunity 2005, 73:7967-7976.
45. Traub S., von A.S., Hartung T., Hermann C. MDP and other muropeptides-direct and synergistic effects on the immune system. Journal of Endotoxin Research 2006, 12:69-85.
46. Uehara A., Takada H. Synergism between TLRs and NOD1/2 in oral epithelial cells. Journal of Dental Research 2008, 87:682-686.
47. van Heel D.A., Ghosh S., Hunt K.A., Mathew C.G., Forbes A., Jewell D.P., Playford R.J. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut 2005, 54:1553-1557.
48. Watanabe T., Kitani A., Murray P.J., Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nature Immunology 2004, 5:800-808.
49. Wehkamp J., Harder J., Weichenthal M., Schwab M., Schaffeler E., Schlee M., Herrlinger K.R., Stallmach A., Noack F., Fritz P., Schroder J.M., Bevins C.L., Fellermann K., Stange E.F. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004, 53:1658-1664.
50. Williams I.R. CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis. Annals of the New York Academy of Sciences 2006, 1072:52-61.
51. Zaki M.H., Boyd K.L., Vogel P., Kastan M.B., Lamkanfi M., Kanneganti T.D. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010, 32:379-391.
52. Zaki M.H., Lamkanfi M., Kanneganti T.D. The Nlrp3 inflammasome: contributions to intestinal homeostasis. Trends in Immunology 2011, 32:171-179.
53. Zhang H., Niesel D.W., Peterson J.W., Klimpel G.R. Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infection and Immunity 1998, 66:5196-5201.